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GlutamateThe zona incerta (ZI) is a subthalamic nucleus connected to several structures, some of them known to be in-
volved with antinociception. The ZI itself may be involved with both antinociception and nociception. The anti-
nociceptive effects of stimulating the ZIwith glutamate using the rat tail-ﬂick test and a ratmodel of incision pain
were examined. The effects of intraperitoneal antagonists of acetylcholine, noradrenaline, serotonin, dopamine,
or opioids on glutamate-induced antinociception from the ZI in the tail-ﬂick test were also evaluated. The injec-
tion of glutamate (7 μg/0.25 μl) into the ZI increased tail-ﬂick latency and inhibited post-incision pain, but did not
change the animal performance in a Rota-rod test. The injection of glutamate into sites near the ZI was non
effective. The glutamate-induced antinociception from the ZI did not occur in animals with bilateral lesion of
the dorsolateral funiculus, or in rats treated intraperitoneally with naloxone (1 and 2 m/kg), methysergide (1 and
2 m/kg) or phenoxybenzamine (2 m/kg), but remained unchanged in rats treated with atropine, mecamylamine,
or haloperidol (all given at doses of 1 and 2 m/kg). We conclude that the antinociceptive effect evoked from the
ZI is not due to a reduced motor performance, is likely to result from the activation of a pain-inhibitory mechanism
that descends to the spinal cord via the dorsolateral funiculus, and involves at least opioid, serotonergic and
α-adrenergic mechanisms. This proﬁle resembles the reported effects of these antagonists on the antinoci-
ception caused by stimulating the periaqueductal gray or the pedunculopontine tegmental nucleus.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The zona incerta (ZI) is a subthalamic nucleus located ventrolateral
to the medial lemniscus and dorsomedial to the substantia nigra
(Ricardo, 1981). Almost all major ascending and descending ﬁber tracts
cross the ZI and target numerous brain centers from the thalamus to the
spinal cord (Mitrofanis, 2005). The ZI seems to be involved with differ-
ent brain functions, such as intake of liquids and food (Gonzalez-Lima
et al., 1993), locomotion (Mogenson et al., 1985), and sexual behavior
(Edwards and Isaacs, 1991). The ZImay also act as a diencephalic center
that initiates and controls responses to a somatic or visceral stimulus
and inﬂuences arousal and attention as well (Mitrofanis, 2005).
There are evidences for the inﬂuence of the ZI on nociception and
antinociception: some neurons in the ZI respond to peripheral noxious
stimulation (Yen et al., 1989; Okada et al., 2002), and their metabolic
activity rises signiﬁcantly during both phases of the response to intra-
plantar formalin (Porro et al., 2003); electrical stimulation of the ZI
produces antinociception in the rat tail-ﬂick test, but strong aversion
was observed during the stimulation period (Prado and Roberts, 1985).
The ZI interconnects with various brainstem nuclei, including the
periaqueductal gray, pedunculopontine tegmental nucleus (PPTg)ology, Faculty of Medicine of
ntes 3900, Ribeirão Preto, SP
36332301.
).
vier OA license.(Ricardo, 1981; Roger and Cadusseau, 1985; Shammah-Lagnado et al.,
1985; Beitz, 1989; Heise and Mitrofanis, 2004), the nucleus raphe
magnus (NRM) (Erzumulu and Killackey, 1980; Ricardo, 1981; Senba
et al., 1981; Peschanski, 1984; Desbois and Villanueva, 2001), giganto-
cellularis nucleus (Giα) (Watanabe and Kawana, 1982; Carlton et al.,
1983) and the anterior pretectal nucleus (APtN) (Foster et al., 1989;
Terenzi et al., 1995; Giber et al., 2008), structures from which electrical
stimulation evokes antinociception (Rees and Roberts, 1993; Millan,
1999).
Stimulation-produced analgesia (SPA) from several brain structures
involves the activation of descending pathways that act to inhibit nox-
ious inputs in the spinal dorsal horn (Millan, 1999). SPA from the
NRM is mediated by serotonergic and opioid mechanisms (Fields and
Basbaum, 1978), while SPA from Giα is mediated by neurons that pro-
ject to and activate spinally projecting noradrenergic neurons located in
the A7 cell group (Clark and Proudﬁt, 1991). Endogenous opioids, sero-
tonin and noradrenaline are involved in mechanisms activated during
SPA from PAG (Millan, 2002), whereas SPA from the APtN is mediated
by opioid and α-adrenergic mechanisms (Rees et al., 1987).
The present study reassessed the effects of stimulating the ZI in the
rat tail-ﬂick test. Intrinsic neurons and many crossing nerve ﬁbers have
been described in the ZI (Masri et al., 2009), and thus stimulation of
the ZI was performed using local injection of glutamate, which is
known to activate cells, but not nerve ﬁbers (Fries and Zieglgansberger,
1974). The effects of stimulating the ZI against post-incision pain in
rats were assessed as well. The effects of intraperitoneal antagonists
361A. Petronilho et al. / Pharmacology, Biochemistry and Behavior 101 (2012) 360–368on glutamate-induced antinociception from the ZI were also evaluat-
ed to determine whether antagonists of acetylcholine, noradrena-
line, serotonin, dopamine, or opioids are effective, as they are
known to be against SPA from PAG, NRM, Giα, or APtN.
2. Materials and methods
2.1. Animals and surgery
Experiments were carried out using male Wistar rats (150–160 g),
provided by the Animal House of the University of São Paulo (USP;
Campus of Ribeirão Preto). These animals were housed in groups of ﬁve
per cage, and given free access to food and water throughout the experi-
ments. The room temperature was controlled (22±1 °C), and a light–
dark cycle (07:00–19:00 h lights on) was maintained. The experiments
were approved by the Commission of Ethics in Animal Research, Faculty
of Medicine of Ribeirão Preto, University of São Paulo (Process number
012/2006). The guidelines of the Committee for Research and Ethical
Issues of IASP (Zimmermann, 1983) were followed throughout the
experiments. Each rat was used on only one occasion. Each animal was
anesthetizedwith tribromoethanol (250 mg/kg, i.p.) and a 12-mm length
of a 23-gauge stainless steel guide cannula was stereotaxically implanted
into the skull until its tip lays 3 mmabove the right ZI. The coordinates (in
mm) were AP=+4.1(from the interaural line), L=−2.3 (from the
sagittal suture), andH=−3.3 (from the skull surface). The guide cannula
was ﬁxed to the skull with two steel screws and dental cement, and kept
patent with a sterile obturator until the time of drug administration. A
group of rats taken for the evaluation of incision pain was contralateral
or bilaterally implanted with guide cannulae in the ZI. After receiving
penicillin (50 mg/kg, i.m.), the animal was allowed to recover for at
least 1 week before the start of the experiments.
2.2. Microinjection procedures
Drug or saline was microinjected into the ZI using a glass needle
(70–80 μm) protected by a system of telescoping steel tubes as de-
scribed elsewhere (Azami et al., 1980). The assembly was inserted
into the guide cannula immediately before microinjection and the nee-
dle advanced to protrude 3 mmbeyond the guide cannula tip. The injec-
tion of 2% lignocaine (0.25 μl) into the dorsal or ventral portions of the
anterior pretectal nucleus signiﬁcantly increased the incision pain in
rats, but the effects from the different parts of the nucleus did not differ
(Villarreal et al., 2004). Therefore, the volume of solution was certainly
diffusing throughout the entire nucleus. The area of the ZI (about
3 mm2) is a bit larger than the area of the anterior pretectal nucleus
(about 2 mm2). By this reason, the volume of 0.25 μl was chosen for
each injection into the ZI. This volume was delivered at a constant
rate over a period of 2 min, and the needle was removed 20 s after the
completion of this procedure.
2.3. Tail-ﬂick test
Each animalwas lightly restrained by handwith the tail laid across a
wire coil at room temperature (23±2 °C). The coil temperature was
then raised by the passage of an electric current and the tail-ﬂick latency
(TFL) was measured. Heat was applied to a portion of the ventral sur-
face of the tail between 4 and 6 cm from the tip. Each trial was terminat-
ed after 6 s to minimize the probability of skin damage. TFL was
measured at 5-min intervals until a stable baseline was obtained over
three consecutive trials. Only rats showing stable baseline TFL after up
to 6 trials were used in each experiment. The animals were then treated
with intraperitoneal saline (control) or antagonist, and the TFL was
measured again within 30 s and then at 5-min interval for up to 3 h
after phenoxybenzamine or 15 min after the other antagonists. Gluta-
mate or saline (0.25 μl) was then injected into the ZI, and the TFL was
measured within 30 s and then at 5-min intervals for up to 15 min.2.4. Model of incision pain
Rats were placed in an elevated clear plastic cagewith a nylonmesh
bottom, which allowed easy access to the paw plantar surface. Before
each test, the animals remained in the cage for 15 min to allow behav-
ioral acclimation. The baseline threshold tomechanical punctate stimu-
lation was measured with an electronic von Frey apparatus (IITC
Electronic Equipments, CA, U.S.A.), consisting of a hand-held probe
unit to which a rigid plastic tip (tip area=0.44 mm2) was connected.
The plastic tip was applied with increasing force in an upward direction
against sites near the heel, 1–2 mmadjacent to themedial border of the
wound and to similar sites in the non-incised hind paw. The movement
of the probe was interrupted when a withdrawal of the stimulated paw
occurred. During this procedure the applied force was continuously
recorded by a main unit connected to the probe. A single trial consisted
of 3 applications of the tip, once every 5 s in each hind paw. Themean of
three readings was taken as the mechanical threshold for a particular
timing. The animal was then anesthetized with isoﬂurane (in oxygen
ﬂow; 2% for induction and 0.5% for maintenance) via a loose-ﬁtting,
cone-shaped mask, and a 1-cm longitudinal incision was made with a
surgical blade through the skin and fascia of the plantar aspect of the
right hind paw, starting 0.5 cm from the proximal edge of the heel, as
described elsewhere (Brennan et al., 1996). The plantaris muscle was
left intact during the procedure. The skin was then sutured with two
5-0 nylon stitches. The thresholds for both hind paws of each rat were
measured 2 h after the incision. A solution (0.25 μl) containing saline
or glutamate was then injected into the ZI contralateral to the incised
paw, and the mechanical threshold for both hind paws of each animal
was measured 30 s later and then at 5-min intervals for up to 25 min.
2.5. Rota-rod
TheRota-rod (UgoBasile, Comerio, Italy) consisted of a 7-cmdiameter
drum rotating at 25 rpm, and was used to assess motor coordination of
rats implanted 1 week earlier with a guide cannula. Each rat was placed
on the drum for up to 2 min and the time of permanence was recorded
on 2 occasions. An initial trial was conducted in naive rats, and the time
spent by each rat on the drum was taken as baseline in the test.
Twenty-four hours later, the time spent by each animal on the drum
was revaluated 30 s after the injection of saline or glutamate into the ZI.
2.6. Dorsolateral funiculus lesion
Rats were initially implanted with the guide cannula directed to the
ZI as described above. Two days later, they were anesthetized with tri-
bromoethanol (250 mg/kg, i.p.), and a lesion of the dorsolateral funicu-
lus (DLF) was made in 8 of them, bilaterally at the T1–T3 level under a
surgical microscope. After laminectomy, the lesionwasmade by cutting
a portion of the dorsolateral quadrant of the spinal cord with a sharp
knife. The overlying muscles and skin were sutured, and the animal
was allowed to recover for at least 5 days before the experiments. The
other rats were submitted to similar procedures, except for the cord le-
sion, and served as sham-lesion rats. DLF-lesion rats were then injected
with saline (4 animals) or glutamate (4–5 animals) in the ZI. Sham-
lesion rats were also injected with saline (4–5 animals) or glutamate
(4–5 animals) in the ZI.
2.7. Histology
At the end of the experiments, the animal was deeply anesthetized
with intraperitoneal sodium thiopental and perfused through the
heart with 4% paraformaldehyde in 0.1 M phosphate buffered saline.
Fast green (1%, 0.25 μl) was injected through the guide cannula to
label the site of intracerebral injection. The brain was removed and
the dye spot localized from 50-μm serial coronal sections stained
with neutral red, and identiﬁed on diagrams from the atlas of
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ted to DLF lesion was removed and the extent of the lesions was
also identiﬁed on diagrams from the same atlas. The ZI is anatomically
divided into the rostral, dorsal, ventral and caudal sectors (Mitrofanis,
2005), but no attempt was made to group the rats according to each
sector.
2.8. Drugs
The following drugs were used: monosodium L-glutamate, atropine
sulfate, mecamylamine, methysergide maleate, naloxone hydrochloride,
phenoxybenzamine, and haloperidol and were purchased from Sigma
(St. Louis, MO, USA). The antagonists were all prepared and diluted in
saline, and their doses referred to the salt. The doses of glutamate used
here (3.5 and 7.0 μg, corresponding to 23 and 47 nmol, respectively)
were within the range (30–60 nmol) proposed elsewhere (Satoh et al.,
1983; Jensen and Yaksh, 1989).
2.9. Data analysis
Tail-ﬂick latencies (in seconds) are reported as means±SEM.
Comparisons between control (rats treated in ZI and intraperitoneally
with saline) and test groups were made by multivariate analysis of
variance (MANOVA) with repeated measures to compare the groups
over all times. The factors analyzed were treatments, time and treat-
ment×time interaction. In the case of treatment×time interaction,
one-way analysis of variance followed by Duncan's test was performed
for each time. The analysis was performed using the statistical software
package SPSS/PC+, version 17.0.
The changes in the animal's performance in the Rota-rod were
compared using ANOVA followed by the Tukey's test. The level of signif-
icance was set at Pb0.05 in all cases.
3. Results
3.1. Antinociception evoked by glutamate from ZI
The groups of rats used in each experiment were not signiﬁcantly
different regarding baseline TFL. Rats injected with saline (0.25 μl;
n=8) into the ZI had TFL that did not differ signiﬁcantly from base-
line throughout the observation period. A strong increase in TFL was
obtained soon after the injection of glutamate (7 μg/0.25 μl; n=8)
into the ZI, the effect remaining signiﬁcantly above control for at
least 5 min (Fig. 1A). A higher dose of glutamate (14 μg/0.25 μl;
n=7) did not induce an additional effect, while a lower dose
(3.5 μg/0.25 μl; n=8) induced a non-signiﬁcant increase in TFL. The
curves in Fig. 1A were signiﬁcantly different regarding treatment
(F3,27=43.62; Pb0.0001), time (F6,162=116.49; Pb0.0001), and
treatment×time interaction (F18,162=27.59; Pb0.0001). During or
after injection of glutamate, no animal showed gross disturbance of
motor coordination or exhibited signs of aversion. The animals
walked normally and responded to non-noxious stimulation through-
out the period of observation. The location of the microinjection sites
is shown in Fig. 1B. Some rats were purposely injected with glutamate
(7 μg/0.25 μl) at sites near the ZI, and the results from sites in the
same region were pooled and compared to that obtained from rats
stimulated with glutamate in the ZI. A strong increase in TFL was con-
ﬁrmed for the injection into the ZI (n=6), but not at sites neighbor-
ing the ZI (Fig. 1C). The location of these sites is shown in Fig. 1D and
includes the ventral posteromedial (n=9) and ventral posterolateral
(n=3) thalamic nuclei, and areas lateral (n=3) or ventral (n=9) to
the ZI.
The time course of the effects produced by the injection of sa-
line or glutamate in the ZI on the post-incision pain is shown in
Fig. 1E. The groups did not differ signiﬁcantly regarding the me-
chanical thresholds for both hind paws measured immediatelybefore the incision (baseline). Two hours after the incision, a re-
duction in the mechanical threshold of the incised paw was ob-
served, thus characterizing the post incision pain. In contrast, no
change was observed in the non-incised hind paw as compared
to baseline. The post incision pain was abolished for at least
10 min after the injection of glutamate (n=5) into the ZI contra-
lateral to the incised paw, but remained unchanged after the in-
jection of saline (n=5) into the same region. The mechanical
threshold of the non incised paw was not changed signiﬁcantly
after the injection of saline (n=5) or glutamate (n=5) into the
ZI. The curves in Fig. 1E were signiﬁcantly different regarding
treatment (F3,20=146.36; Pb0.0001) and time (F10,200=105,45;
Pb0.0001), and had signiﬁcant treatment×time interaction
(F30,200=53.74; Pb0.0001). The location of the injection sites in
the ZI is shown in Fig. 1F. The mechanical threshold of both
hind paws of non incised rats was not changed signiﬁcantly
after the injection of saline (n=5) or glutamate (n=5) bilateral
into the ZI (Fig. 1G). The curves in Fig. 1G were not signiﬁcantly
different regarding treatment (F3,18=0; P=0.89) and time
(F6,108=1.06; P=0.53), nor had signiﬁcant treatment×time in-
teraction (F18,108=4.08; P=0.3). The location of the injection
sites in the ZI is shown in Fig. 1H. Representative microscope
image with a dye spot restrict to the ZI is shown in Fig. 2.3.2. Effect of dorsolateral funiculus lesion on the antinociception evoked
by glutamate from ZI
The injection of saline (0.25 μl) into the ZI of DLF-lesion (n=5)
or sham DLF-lesion (n=4) rats did not produce signiﬁcant changes
in TFL regarding baseline values. A strong increase in TFL following
the injection of glutamate (7 μg/0.25 μl) into the ZI was conﬁrmed
in sham (n=5) DLF-lesion, but not in real (n=6) DLF-lesion rats
(Fig. 3A). The curves in Fig. 3A were signiﬁcantly different regarding
treatment (F(3,16)=9.43; Pb0.001), time (F(6,96)=8.38; Pb0.001)
and treatment versus time interaction (F(18,96)=5.61; Pb0.001).
The extent of the DLF lesion is shown in Fig. 3B to demonstrate
that the tissue damage was restricted to the DLF and the adjacent
dorsal horn. The location of the injection sites in the ZI at which glu-
tamate induced antinociceptive effect is shown in Fig. 3C.
The injection of saline (0.25 μl) bilateral into the ZI of DLF-
lesion (n=4) or sham DLF-lesion(n=5) rats also did not produce
signiﬁcant changes in mechanical threshold of incised paw regard-
ing pre incision values. The post incision pain was abolished for at
least 10 min after the injection of glutamate (7 μg/0.25 μl) bilateral
into the ZI of sham (n=5) DLF-lesion, but remained unchanged
after similar procedure in real (n=5) DLF-lesion rats (Fig. 4A).
In this experiment, the mechanical threshold of non incised
paws was also increased after glutamate (not shown in ﬁgures).
The extent of the DLF lesion is shown in Fig. 4B and the location
of the injection sites in the ZI at which glutamate induced antino-
ciceptive effect is shown in Fig. 4C.3.3. Effects of injecting glutamate into the ZI on the Rota-rod
performance
Two groups of 5 rats each were used in this experiment and
the results are shown in Fig. 5A. The groups did not differ signif-
icantly with regard to baseline performance on the Rota-rod.
Rats injected with saline (0.25 μl) had performances that did not
differ signiﬁcantly from baseline. Similar results were obtained
with rats injected with glutamate (7 μg/0.25 μl). The data in Figs. 5A
were signiﬁcantly different (ANOVA: F3,23=2.99; P=0.71). The
location of the injection sites in the ZI for this experiment is shown
in Fig. 5B.
Fig. 1. Time course of the changes in tail-ﬂick latency (A and C) or incision pain (E) produced by the injection (arrow) of saline (0.25 μl) or glutamate into the ZI (A and E) or at sites
within or near the ZI (C). A surgical incision was performed in the plantar aspect of the right paw. The effects of the injection of saline or glutamate bilateral into the ZI on the me-
chanical threshold of both hind paws of non incised rats are shown in G. The doses of glutamate are given in A as μg/0.25 μl. In C, E and G, glutamate was used at a dose of 7 μg/
0.25 μl. In E, glutamate was injected into the ZI contralateral to the incised paw. Points are means±S.E.M. of 7–8 animals in A, 3–9 animals in C, and 5 animals in E and G. Points
are different from saline-treated rats (*) or from all the other groups (#), Pb0.05. The location of injection sites for the experiments shown in A, C, E and G is shown in B, D, F and H,
respectively, on diagrams taken from Paxinos andWatson (1986). Abbreviations: VPM= ventral posteromedial thalamic nucleus; VPL= ventral posterolateral thalamic nucleus; ZI
= zona incerta; RP = right paw; LP = left paw.
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induced antinociception from ZI
Rats pretreated intraperitoneally with saline, methysergide, nal-
oxone, phenoxybenzamine, atropine, mecamylamine, or haloperidolwere injected with saline (0.25 μl) or glutamate (7 μg/0.25 μl) into
the ZI. Glutamate or saline was injected into the ZI 3 h after phenox-
ybenzamine and 15 min after the other antagonists. No change in TFL
was produced by the injection of saline into the ZI of rats treated in-
traperitoneally with saline (0.1 ml/kg; n=7), compared to baseline
Fig. 2. Representative microscope image taking from neutral red-stained brain slices. It
shows a dye spot produced by the injection of Fast green (0.25 μl) into the zona incerta.
Abbreviations: lm =medial lemniscus; ic = internal capsule; cp = cerebral peduncle;
F = nucleus ﬁelds of Forel.
Fig. 4. Time course of the changes in incision pain produced by the bilateral injection
(arrow) of saline (0.25 μl) or glutamate (7 μg/0.25 μl) into the ZI of sham (sDLF) or dor-
solateral funiculus (DLF)-lesion rats. The extent of DLF lesion and the location of stim-
ulation sites of DLF/glu rats are shown at the bottom of diagrams taken from Paxinos
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after the injection of glutamate into the ZI in saline-treated rats
(n=8), the effect being signiﬁcantly higher than in control for 5 to
10 min. The effect of glutamate was fully blocked by naloxone (1
and 2 m/kg; n=5 and 6, respectively) (Fig. 6A) and reduced in a
dose-dependent manner by methysergide (1 and 2 mg/kg; n=7 inFig. 3. Time course of the changes in tail-ﬂick latency produced by the injection
(arrow) of saline (0.25 μl) or glutamate (7 μg/0.25 μl) into the ZI of sham (sDLF) or dor-
solateral funiculus (DLF)-lesion rats. The extent of DLF lesion and the location of stim-
ulation sites of DLF/glu rats are shown at the bottom of diagrams taken from Paxinos
and Watson (1986). Points on the graph are means±S.E.M. of 4–6 animals. (#) Differ-
ent from the other groups, Pb0.05.
and Watson (1986). Points on the graph are means±S.E.M. of 4–5 animals. (#) Differ-
ent from the other groups, Pb0.05.
Fig. 5. The effects of the injection of saline (0.25 μl) or glutamate (7 μg/0.25 μl) into the
ZI on the motor performance of rats in the Rota-rod test (A). Bars are means±S.E.M. of
5 animals per group. The location of injection sites for the experiment is shown in B
using open (saline) and black (glutamate) symbols on diagrams taken from Paxinos
and Watson (1986).
Fig. 6. Changes produced by intraperitoneal (arrow 1) saline (0.1 ml/kg), naloxone (A) or methysergide (B) on the effects of saline (0.25 μl) or glutamate (7 μg/0.25 μl) injected into
the ZI of rats (arrow 2). The doses of naloxone (nlx) and methysergide (met) are given in μg/kg. The location of injection sites is shown in C and D, using the symbols as they appear
in A and B, respectively. The location of injection sites corresponding to control groups (sal/sal and sal/glu) of experiments A and B is shown in E. Symbols are shown on diagrams
taken from Paxinos and Watson (1986) and may represent more than one animal at a coincident site. Points on the graph are means±S.E.M of 5 to 8 animals per group. (*) Dif-
ferent from control (sal/sal), Pb0.05.
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methysergide (0.5 mg/kg; n=6) did not change the effect of gluta-
mate (Fig. 6A and B, respectively). The injection of saline into the ZI
of rats treated intraperitoneally with the higher dose of naloxone
(n=5) or methysergide (n=8) did not change TFL as compared to
control. The location of the sites of injection into the ZI is shown for
naloxone- (Fig. 6C), methysergide- (Fig. 6D), and saline- (Fig. 6E)
treated rats. The curves in Fig. 6A and B were signiﬁcantly different
regarding treatment (F(5,30)=9.50 and F(5,37)=45.75, respectively;
Pb0.001), time (F(8,240)=25.75 and F(8,296)=73.02, respectively;
Pb0.0001), and treatment versus time interaction (F(40,240)=5.47
and F(40,296)=10.71; Pb0.0001).
Intraperitoneal phenoxybenzamine (2 mg/kg; n=6) also signif-
icantly reduced the glutamate-induced antinociception from the ZI
(Fig. 7A). Phenoxybenzamine (0.5 and 1 mg/kg; n=6 and 8, respec-
tively), atropine (1 and 2 mg/kg; n=6 in both cases), mecamyl-
amine (1 and 2 mg/kg; n=7 and 6, respectively), or haloperidol (1
and 2 mg/kg; n=7 and 6, respectively), was ineffective as com-
pared to the effect of glutamate in saline-treated rats (Fig. 7A to D,
respectively). The injection of saline into the ZI of rats treated intra-
peritoneally with the higher dose of phenoxybenzamine (n=8), at-
ropine (n=8), mecamylamine (n=6) or haloperidol (n=8) did
not change TFL as compared to control. The curves in Fig. 7A to D
were signiﬁcantly different regarding treatment (F(5,35)=20.06,
F(4,29)=25.63, F(4,29)=12.12, and F(4,32)=25.05, respectively;
Pb0.001), time (F(8,280)=89.66, F(8,232)=54.88, F(8,232)=36.79,
and F(8,256)=136.37, respectively; Pb0.001), and treatment versus
time interaction (F(40,280)=10.35, F(32,232)=11.92, F(32,232)=4.88,
and F(32,256)=18.87, respectively; Pb0.0001). The location of the
sites of injection into the ZI in these experiments is shown in
Fig. 7E to H, respectively.4. Discussion
The present study demonstrates that injection of glutamate into
the ZI, but not at sites near the ZI, produces a strong but short-
duration antinociception in the rat tail-ﬂick test. The injection of glu-
tamate into the ZI also produced analgesic effect in a rat model of in-
cision pain. Because glutamate preferentially excites neuronal cell
bodies but not ﬁbers (Fries and Zieglgansberger, 1974), we may con-
clude that increasing the activity of neuronal cells in the ZI leads to
antinociception. In addition, the effect of glutamate is unlikely the re-
sult of drug spreading to structures near the ZI. Glutamatergic cells
have already been shown in the ZI (Kolmac and Mitrofanis, 1999),
but parvalbumin, nitric oxide synthase, GABAergic, somatostatin, do-
paminergic, enkephalinergic, calbindin D28k, and γ-melanocyte stim-
ulating hormone-like cells have been described in the ZI as well
(Mitrofanis, 2005). Whether or not glutamate plays a physiological
role as a neurotransmitter involved with antinociception in the ZI re-
mains to be determined.
The glutamate-induced antinociception from the ZI in the tail ﬂick
test and post incision pain did not occur in animals with bilateral DLF
lesions. The DLF is the main route through which most of the des-
cending pain-inhibitory pathways travel (Fields and Basbaum,
1978). Therefore, the antinociceptive effect evoked from the ZI is like-
ly to result from the activation of a pain-inhibitory mechanism that
descends to the spinal cord via the DLF. The injection of glutamate
into the ZI had no effect on the mechanical threshold of non incised
rats. We may then conclude that mechanisms activated by glutamate
from the ZI inhibit post incision pain but not non-evoked pain
behavior.
Masri et al. (2009) have shown that lesions of the spinal cord re-
duce the activity of ZI neurons. As a result, the present ﬁnding that
Fig. 7. Changes produced by intraperitoneal (arrow 1) saline (0.1 ml/kg), phenoxybenzamine (A), atropine (B), mecamylamine (C) or haloperidol (D) on the effects of saline
(0.25 μl) or glutamate (7 μg/0.25 μl) injected into the ZI of rats (arrow 2). The doses of phenoxybenzamine (pbz), atropine (atr), mecamylamine (mec), and haloperidol (hal)
are given in μg/kg. The location of injection sites for the experiments shown in A to D is shown in E to H, respectively, on diagrams taken from Paxinos and Watson (1986), and
may represent more than one animal at a coincident site. The location of injection sites corresponding to groups sal/sal and sal/glu in B is the same as shown in Fig. 3E. Points
are means±S.E.M of 4 to 8 animals per group. (*) Different from control (sal/sal); (#) different from all the other groups, Pb0.05.
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suppressed activity of ZI. However, the extent of the DLF lesion used
in the present study was limited to the superﬁcial dorsal horn,
while the anterolateral quadrant of the spinal cord and the ventral
and ventrolateral funiculi were targeted in Masri's experiment. There-
fore, the suppressed activity of the ZI consequent to spinal lesion is un-
likely to be the reason for the lack of analgesic effect of stimulating the
ZI in DLF-lesion animals.
The ZI plays a role in locomotor activity and this role is supported by
anatomical evidences of ZI connections with motor-related centers,
such as the red nucleus, the pontine nuclei and several hypothalamic nu-
clei, the cervical and lumbosacral regions of the spinal cord (Mitrofanis,
2005). We found here that the injection of glutamate into the ZI was
not followed by changes of the animal performance in a Roda-rod test,
which is used to assess motor changes (Dunham and Miya, 1957). We
may then conclude that the antinociceptive effect shown here is unlikely
to result from a motor side effect of stimulating the ZI with glutamate.
Compared to control, the glutamate-induced antinociception from
the ZI was prevented by intraperitoneal naloxone, methysergide
or phenoxybenzamine (non-selective opioid, serotonergic and α-adrenergic antagonist, respectively). In contrast, intraperitoneal
atropine, mecamylamine, or haloperidol (non-selective muscarin-
ic, nicotinic, and dopaminergic antagonists, respectively) was inef-
fective against glutamate-induced analgesia from the ZI even
though used at doses equal to or higher than those shown to be
effective against chemically or electrically induced antinociception
(Sahley and Berntson, 1979; Drago et al., 1984; Rees et al., 1987).
Therefore, at least, serotonergic, α-adrenergic, and endogenous
opioid mechanisms but not cholinergic or dopaminergic mecha-
nisms seem to be involved in the modulation of the glutamate-
induced antinociception from the ZI. However, we cannot make
conclusions about the particular site of action for each of the an-
tagonists while using systemic antagonists.
Autoradiographic experiments showed connections from the ZI to
the thalamus, hypothalamus, APtN, superior colliculus, PAG, cunei-
form nucleus, red nucleus, PPTg, NRM and Giα (Watanabe and
Kawana, 1982; Carlton et al., 1983). Glutamatergic projections from
the ZI to PAG (Beitz, 1989) and PPTg (Heise and Mitrofanis, 2004)
have already been demonstrated. The ZI also projects to the PAG
and APtN in rats (Foster et al., 1989). The PAG (see Millan, 1999),
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1993) and APtN (see Rees and Roberts, 1993) are structures from
which electrical stimulation evokes antinociception. ZI efferents
terminating within the spinal gray matter, particularly the ventral
horn, have already been demonstrated (Ricardo, 1981; Watanabe
and Kawana, 1982; Peschanski et al., 1983; Roger and Cadusseau,
1985; Romanowski et al., 1985; Shammah-Lagnado et al., 1985;
Shiosaka et al., 1985; Shaw and Mitrofanis, 2001, 2002).
The stimulation-produced antinociception from the PAG activates
opioid and monoamine systems in the brain because naloxone and
monoamine antagonists potently reduce the effects of PAG stimulation
(Basbaum and Fields, 1978).
The SPA from the NRM is mediated by serotonergic and endogenous
opioid but not noradrenergic mechanisms (Fields and Basbaum, 1978;
Azami et al., 1982), while noradrenaline but not serotonin mediates
the effect from the parabrachial nucleus and locus coeruleus (see
Millan, 2002). Giα neurons that project to and activate spinally project-
ing noradrenergic neurons located in the A7 cell group are involved in
the mediation of the SPA from the Giα (Clark and Proudﬁt, 1991).
The stimulation-induced antinociception from the PPTg is blocked
by systemic naloxone, methysergide, phenoxybenzamine and atropine,
but not by propranolol, haloperidol or mecamylamine (Dias et al.,
2009). The PPTg participates as a relay station in a descending pathway
from the APtN (Terenzi et al., 1992), a brain structure fromwhich elec-
trical stimulation produces a strong and long-lasting antinociception,
which is mediated by opioid, α-adrenergic and muscarinic cholinergic
mechanisms (Rees et al., 1987).
The injection of glutamate into the ZI inhibits the rat tail-ﬂick reﬂex
by mechanisms that resemble those activated by PAG or PPTg stimula-
tion. Similarities include the effectiveness of opioid, serotonergic and
α-adrenoceptor antagonists. Differing from the effect from the ZI,
the SPA from the PPTg was sensitive to systemic atropine. The ZI
was stimulated here with glutamate which certainly activates the
brain structure in a manner more restricted than that provided by
electrical stimulation, as utilized in the aforementioned studies.
5. Conclusions
The injection of glutamate into the rat ZI produces a strong but
short-duration antinociception that does not occur in DLF-lesion rats
or in rats pretreated intraperitoneally with naloxone, methysergide or
phenoxybenzamine. Therefore, the effect of the ZI is likely to result
from the activation of a pain-inhibitory pathway that descends to the
spinal cord via the DLF and involves at least opioid, serotonergic and
α-adrenergic mechanisms.
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